Literature DB >> 25489059

Prenatal testosterone exposure induces hypertension in adult females via androgen receptor-dependent protein kinase Cδ-mediated mechanism.

Chellakkan S Blesson1, Vijayakumar Chinnathambi2, Gary D Hankins2, Chandra Yallampalli1, Kunju Sathishkumar2.   

Abstract

Prenatal exposure to excess testosterone induces hyperandrogenism in adult females and predisposes them to hypertension. We tested whether androgens induce hypertension through transcriptional regulation and signaling of protein kinase C (PKC) in the mesenteric arteries. Pregnant Sprague-Dawley rats were injected with vehicle or testosterone propionate (0.5 mg/kg per day from gestation days 15 to 19, SC) and their 6-month-old adult female offspring were examined. Plasma testosterone levels (0.84±0.04 versus 0.42±0.09 ng/mL) and blood pressures (111.6±1.3 versus 104.5±2.4 mm Hg) were significantly higher in prenatal testosterone-exposed rats compared with controls. This was accompanied with enhanced expression of PKCδ mRNA (1.5-fold) and protein (1.7-fold) in the mesenteric arteries of prenatal testosterone-exposed rats. In addition, mesenteric artery contractile responses to PKC activator, phorbol-12,13-dibutyrate, was significantly greater in prenatal testosterone-exposed rats. Treatment with androgen receptor antagonist flutamide (10 mg/kg, SC, BID for 10 days) significantly attenuated hypertension, PKCδ expression, and the exaggerated vasoconstriction in prenatal testosterone-exposed rats. In vitro exposure of testosterone to cultured mesenteric artery smooth muscle cells dose dependently upregulated PKCδ expression. Analysis of PKCδ gene revealed a putative androgen responsive element in the promoter upstream to the transcription start site and an enhancer element in intron-1. Chromatin immunoprecipitation assays showed that androgen receptors bind to these elements in response to testosterone stimulation. Furthermore, luciferase reporter assays showed that the enhancer element is highly responsive to androgens and treatment with flutamide reverses reporter activity. Our studies identified a novel androgen-mediated mechanism for the control of PKCδ expression via transcriptional regulation that controls vasoconstriction and blood pressure.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; polycystic ovary syndrome; protein kinase C; testosterone; vasoconstriction

Mesh:

Substances:

Year:  2014        PMID: 25489059      PMCID: PMC4326589          DOI: 10.1161/HYPERTENSIONAHA.114.04521

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  61 in total

Review 1.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

2.  Increased Ca2+ sensitivity of contractile elements via protein kinase C in alpha-toxin permeabilized SMA from young spontaneously hypertensive rats.

Authors:  H Sasajima; H Shima; Y Toyoda; K Kimura; A Yoshikawa; T Hano; I Nishio
Journal:  Cardiovasc Res       Date:  1997-10       Impact factor: 10.787

3.  Identification and characterization of an androgen-responsive Kap promoter enhancer located in the intron II region of human angiotensinogen gene.

Authors:  Li-qiang Fan; Dianne O Hardy; James F Catterall; Jian Zhao; Su-xia Li
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-12       Impact factor: 4.292

4.  Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.

Authors:  G A Laughlin; E Barrett-Connor; D Kritz-Silverstein; D von Mühlen
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

5.  Exercise and hypercholesterolemia produce disparate shifts in coronary PKC expression.

Authors:  Donna H Korzick; Megan E Rishel; Douglas K Bowles
Journal:  Med Sci Sports Exerc       Date:  2005-03       Impact factor: 5.411

6.  Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study.

Authors:  Sarah C Kent; Carol L Gnatuk; Allen R Kunselman; Laurence M Demers; Peter A Lee; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

7.  Testosterone alters maternal vascular adaptations: role of the endothelial NO system.

Authors:  Vijayakumar Chinnathambi; Meena Balakrishnan; Jayanth Ramadoss; Chandrasekhar Yallampalli; Kunju Sathishkumar
Journal:  Hypertension       Date:  2013-01-21       Impact factor: 10.190

8.  Protein kinase C activity in blood vessels from normotensive and spontaneously hypertensive rats.

Authors:  E Bazan; A K Campbell; R M Rapoport
Journal:  Eur J Pharmacol       Date:  1992-11-02       Impact factor: 4.432

9.  Ca(2+)-independent isoforms of protein kinase C differentially translocate in smooth muscle.

Authors:  R A Khalil; C Lajoie; M S Resnick; K G Morgan
Journal:  Am J Physiol       Date:  1992-09

Review 10.  Intrauterine programming of physiological systems: causes and consequences.

Authors:  Abigail L Fowden; Dino A Giussani; Alison J Forhead
Journal:  Physiology (Bethesda)       Date:  2006-02
View more
  15 in total

1.  Hyperandrogenemia reduces endothelium-derived hyperpolarizing factor-mediated relaxation in mesenteric artery of female rats.

Authors:  Jay S Mishra; Amar S More; Gary D V Hankins; Sathish Kumar
Journal:  Biol Reprod       Date:  2017-06-01       Impact factor: 4.285

2.  Elevated Testosterone Reduces Uterine Blood Flow, Spiral Artery Elongation, and Placental Oxygenation in Pregnant Rats.

Authors:  Kathirvel Gopalakrishnan; Jay S Mishra; Vijayakumar Chinnathambi; Kathleen L Vincent; Igor Patrikeev; Massoud Motamedi; George R Saade; Gary D Hankins; Kunju Sathishkumar
Journal:  Hypertension       Date:  2016-01-18       Impact factor: 10.190

Review 3.  Developmental Programming of Hypertension: Physiological Mechanisms.

Authors:  John Henry Dasinger; Gwendolyn K Davis; Ashley D Newsome; Barbara T Alexander
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

Review 4.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

5.  Circular RNA expression profiling in the fetal side of placenta from maternal polycystic ovary syndrome and circ_0023942 inhibits the proliferation of human ovarian granulosa cell.

Authors:  Chengcheng Zhao; Yu Zhou; Xia Shen; Min Gong; Yingfei Lu; Chao Fang; Jianquan Chen; Rong Ju
Journal:  Arch Gynecol Obstet       Date:  2020-03-19       Impact factor: 2.344

6.  Testosterone plays a permissive role in angiotensin II-induced hypertension and cardiac hypertrophy in male rats.

Authors:  Jay S Mishra; Amar S More; Kathirvel Gopalakrishnan; Sathish Kumar
Journal:  Biol Reprod       Date:  2019-01-01       Impact factor: 4.285

7.  Sexual dimorphism in testosterone programming of cardiomyocyte development in sheep.

Authors:  Adel Ghnenis; Vasantha Padmanabhan; Arpita Vyas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-04       Impact factor: 4.733

Review 8.  Let's Talk about Placental Sex, Baby: Understanding Mechanisms That Drive Female- and Male-Specific Fetal Growth and Developmental Outcomes.

Authors:  Ashley S Meakin; James S M Cuffe; Jack R T Darby; Janna L Morrison; Vicki L Clifton
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

9.  Prenatal Testosterone Exposure Leads to Gonadal Hormone-Dependent Hyperinsulinemia and Gonadal Hormone-Independent Glucose Intolerance in Adult Male Rat Offspring.

Authors:  Amar S More; Jay S Mishra; Kathirvel Gopalakrishnan; Chellakkan S Blesson; Gary D Hankins; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2015-11-19       Impact factor: 4.285

10.  Prenatal Testosterone Exposure Decreases Aldosterone Production but Maintains Normal Plasma Volume and Increases Blood Pressure in Adult Female Rats.

Authors:  Amar S More; Jay S Mishra; Gary D Hankins; Sathish Kumar
Journal:  Biol Reprod       Date:  2016-07-06       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.